New oral study medication for patients with Post Herpetic Neuralgia (PHN)

This is a study of an oral investigational medication for patients with PHN for approximately 6-7 weeks.

  • Ages 18 and older
  • Must have had PHN pain from shingles for 6 months or longer with no residual rash
  • Patients must not use any other medications for pain during the study period.